S/GSK1349572 – Targeting the ubiquitin–proteasome system for cancer therapy

Our data in aggregate claim that stromal cells in AML individuals

January 11, 2019 by Katherine Lewis Leave a Comment

Our data in aggregate claim that stromal cells in AML individuals undergo modification which includes modifications in work as very well as the proteins and RNA within the exosomes they launch. We report an initial demo that stromal cells in AML launch exosomes enriched for known medical risk elements, including TGFB1, and em MIR375 /em … [Read more…]

Pluripotent parthenogenetic stem cells (pSCs) may be derived by pharmacological activation

February 11, 2018 by Katherine Lewis Leave a Comment

Pluripotent parthenogenetic stem cells (pSCs) may be derived by pharmacological activation of unfertilized oocytes. line with our observation, Rosa et al. showed that native myocardium does not express MHC class I antigens, but after transplantation these antigens can be induced (28). It was demonstrated that fetal and adult myocytes express very low levels of MHC … [Read more…]